Used as an intermediate in the synthesis of pharmaceutical compounds related to the central nervous system, particularly in pharmaceutical research aimed at developing new drugs for psychiatric or neurological disorders, such as depression, anxiety, or schizophrenia. Its structure enables good penetration of the blood-brain barrier, providing potential activity on brain receptors, especially serotonergic and dopaminergic types. Therefore, it is used in the lead compound selection process for designing drugs with targeted effects and reduced side effects.